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RNA polymerase III (Pol III) occurs in two versions, one containing the POLR3G subunit and the other the closely related
POLR3GL subunit. It is not clear whether these two Pol III forms have the same function, in particular whether they
recognize the same target genes. We show that the POLR3G and POLR3GL genes arose from a DNA-based gene duplication,
probably in a common ancestor of vertebrates. POLR3G- as well as POLR3GL-containing Pol III are present in cultured cell
lines and in normal mouse liver, although the relative amounts of the two forms vary, with the POLR3G-containing Pol III
relatively more abundant in dividing cells. Genome-wide chromatin immunoprecipitations followed by high-throughput
sequencing (ChIP-seq) reveal that both forms of Pol III occupy the same target genes, in very constant proportions within
one cell line, suggesting that the two forms of Pol III have a similar function with regard to specificity for target genes. In
contrast, the POLR3G promoter—not the POLR3GL promoter—binds the transcription factor MYC, as do all other pro-
moters of genes encoding Pol III subunits. Thus, the POLR3G/POLR3GL duplication did not lead to neo-functionalization of
the gene product (at least with regard to target gene specificity) but rather to neo-functionalization of the transcription
units, which acquired different mechanisms of regulation, thus likely affording greater regulation potential to the cell.
[Supplemental material is available for this article.]
The three main nuclear eukaryotic RNA polymerases (pols) are
issued from a common ancestor and have remained highly similar
to each other during eukaryotic evolution (Werner andGrohmann
2011). They consist of a 10-subunit core containing five common
subunits and five subunits related among the three enzymes, as
well as additional subcomplexes (for a compilation of the various
subunit names in Homo sapiens, Mus musculus, and Saccharomyces
cerevisiae, see Supplemental Table S1; for reviews, see Cramer et al.
2008; Vannini and Cramer 2012). The subcomplex forming the
RNA polymerase stalk consists of two subunits that have little se-
quence conservation among polymerases but are clearly related in
their three-dimensional structure. Another two-subunit sub-
complex present in Pol I and Pol III has structural similarity to the
two-subunit TFIIF Pol II general transcription factor (Kuhn et al.
2007; Carter and Drouin 2010; Geiger et al. 2010). The third sub-
complex has partial structural similarity to TFIIE (Geiger et al.
2010; Lefevre et al. 2011). In Pol III, this subcomplex, which is
detachable from the rest of the enzyme (Werner et al. 1992, 1993;
Wang and Roeder 1997), contains the subunits POLR3C (RPC3/
RPC62) and POLR3F (RPC6/RPC39), with structural similarities to
GTF2E1 (TFIIE-A) and GTF2E2 (TFIIE-B), respectively, as well as the
subunit POLR3G (RPC7/RPC32-alpha), the only polymerase sub-
unit without an identified counterpart in the other two tran-
scription machineries.
Pol III is recruited to its target promoters through the forma-
tion of transcription initiation complexes that invariably contain
TFIIIB. In yeast, TFIIIB consists of three subunits, the TATA box
binding protein Spt15 (Tbp), the SANT domain protein Bdp1, and
the TFIIB-related factor Brf1. In mammalian cells, two forms of
TFIIIB exist, BRF1-TFIIIB and BRF2-TFIIIB, in which BRF1 is
replaced by another TFIIB-related factor, BRF2 (Geiduschek and
Kassavetis 2001; Schramm and Hernandez 2002; Jawdekar and
Henry 2008). The trimeric POLR3C (RPC3)-POLR3F (RPC6)-
POLR3G (RPC7) complex plays a role in transcription initiation
complex formation (Thuillier et al. 1995; Brun et al. 1997; Wang
and Roeder 1997), at least in part through direct contacts with
TFIIIB: The yeast homolog of human POLR3F, Rpc34, has been
shown to associate with Brf1 (Werner et al. 1993), and human
POLR3F with both BRF1 and TBP (Wang and Roeder 1997).
Moreover, down-regulation of POLR3F in mammalian cells pre-
vents Pol III association with its target genes (Kenneth et al. 2008).
Consistent with the structural similarities of POLR3C and POLR3F
with TFIIE subunits, the trimeric complex stabilizes the open
preinitiation complex (Brun et al. 1997).
Recently, an isoform of POLR3G, RPC32-beta or POLR3GL
(RPC7-Like, RPC7L), encoded by a separate gene, was identified
by database searches (Haurie et al. 2010). Interestingly, the two
isoforms were found to be differentially expressed, with POLR3G
(RPC32-alpha) decreasing during differentiation and increasing
during cellular transformation relative to POLR3GL (Haurie et al.
2010). Indeed, POLR3G is one of the most highly up-regulated
genes in undifferentiated human stem cells relative to differenti-
ated cells (Enver et al. 2005), and decreasing its levels results in loss
of pluripotency (Wong et al. 2011). Suppression of each isoform by
siRNA suggested that POLR3GL, but not POLR3G, is essential for
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cell survival. Moreover, ectopic expression of POLR3G, but not
POLR3GL, leads to anchorage-independent growth in partially
transformed human IMR90 fibroblasts (Haurie et al. 2010). Together,
these results suggest that POLR3G and POLR3GL carry out different
functions in the cell, but what these functions may be is unclear.
We identified POLR3GL during a mass spectrometry analysis
of Pol III highly purified from HeLa cells, and determined that
these cells contain two forms of Pol III, one containing POLR3G
and the other POLR3GL, consistent with previous results (Haurie
et al. 2010).We show that POLR3G and POLR3G arose from aDNA-
based gene duplication, probably in a common ancestor of verte-
brates, and we describe the genome-wide occupancy of these two
forms of Pol III in IMR90 cells, a nontransformed and non-
immortalized human cell line, as well as in normalmouse liver and
mouse hepatocarcinoma cells. The results allow us to refine the list
of Pol III–occupied loci in human and mouse cells, and confirm
that only a small number of SINEs or nonannotated (NA) loci are
clearly occupied by Pol III in addition to known Pol III genes. They
also show that the large majority of Pol III–occupied loci are more
occupied in hepatocarcinoma cells compared with mouse liver
cells, consistent with the idea that Pol III transcription is up-reg-
ulated in cancer cells. Most importantly, the results indicate that
both forms of Pol III occupy the same target genes but that POLR3G
and POLR3GL expression is differentially regulated, most likely at
least in part by the transcription factor MYC. The POLR3G/
POLR3GL gene duplication seems thus to have led to neo-func-
tionalization of the transcription units, which have acquired dif-
ferent mechanisms of regulation, rather than to neo-functionali-
zation of the gene products.
Results
Identification of POLR3GL (RCP7L) in highly purified Pol III
We used a HeLa cell line (9-8) expressing a Flag- and His-tagged
POLR3D (RPC4) Pol III subunit (Hu et al. 2002) to purify Pol III
extensively, as summarized in Supplemental Figure S1A. The
resulting preparations, purified either through the Flag tag or
through both the Flag and His tags (Supplemental Fig. S1B), were
subjected to global mass spectrometry analysis. In addition to all
the previously described Pol III subunits, a subunit sharing 49%
amino acid identities with POLR3G (RPC7), POLR3GL (RPC7L),
was detected in both singly and doubly affinity chromatography-
purified material. As shown in Supplemental Figure S1C, the
peptides detected were all specific to either POLR3G or POLR3GL,
excluding any ambiguity as to the identity of the corresponding
protein sequence. The ratios of POLR3GL over POLR3G, as de-
termined by normalized spectral abundance factor (see Methods),
were 0.45 and 0.53 in the singly and doubly purified material, re-
spectively, indicating a lower amount of POLR3GL than POLR3G
in these transformed cells. POLR3G and POLR3GL proteins cor-
respond to the RPC32-alpha and RPC32-beta proteins described by
Haurie et al. (2010) and are encoded by two different genes:
POLR3G located on chromosome 5 and POLR3GL located on
chromosome 1, respectively.
The discovery of a POLR3G-related gene prompted us to ex-
amine whether other, so far undetected, Pol III subunit homologs
might exist. We examined the human genome for sequences po-
tentially encoding proteins with homology with any of the known
Pol III subunits. Apart from POLR3GL and the genes encoding
known Pol I and Pol II paralogs of Pol III subunits, we detected
ORFs encoding putative homologs of POLR3K (RPC10) and
POLR2K (RPABC4) (Supplemental Fig. S1D). However, unlike the
POLR3GL ORF, these ORFs were not interrupted by introns, sug-
gesting that they arose by recent retroduplication, and neither
sequence could be found in the EST database, indicating that,
consistent with the lack of any corresponding peptides in our Pol
III preparation, they are unlikely to be expressed.
Evolution of the POLR3G and POLR3GL genes
The POLR3G and POLR3GL genes code for proteins with 46%
amino acid identities, strongly suggesting that they arose from
duplication. To examinewhether the duplication arose through an
RNA- or DNA-based event, we compared the genomic structure of
the human POLR3G and POLR3GL genes. Although the intron
sequences are not conserved between the two genes, the division
of the protein-coding sequence into seven exons is close to iden-
tical in the two genes, as shown in Figure 1, A and B. This implies
that the duplication did not occur by retroduplication, giving rise
to a processed gene that would have then acquired introns, but
rather by a DNA-based event.
We then examine the number of POLR3G/POLR3GL genes in
some of the available genomes, aswell as the number of BRF1/BRF2
genes, which, like POLR3G/POLR3GL, code for a subunit of a
complex required for Pol III transcription, in this case TFIIIB. As
shown in Figure 1C, we could identify only one BRF gene in S.
cerevisiae, as expected, as well as in Caenorhabditis elegans and
Drosophila melanogaster. We also found only one gene in Ciona
intestinalis, a representative of the vase tunicates, the closest par-
ents of vertebrates, and in Petromyzon marinus, a representative of
agnaths (jawless vertebrates), a very ancient vertebrate lineage. In
contrast, all gnathostomes genomes examined contained two
genes except for the fish Takifugu rubripes, which contained three,
two of which are close to BRF1 and one to BRF2. In the case of the
POLR3G/POLR3GL genes, we found one gene in S. cerevisiae, C.
elegans, and D. melanogaster; one gene also in C. intestinalis and P.
marinus; and one, two, or three genes in other vertebrates. These
observations suggested that the POLR3G/POLR3GL duplication
might have occurred in the common ancestor of vertebrates or
of gnathostomes.
In an attempt to time the POLR3G/POLR3GL duplication, we
performed protein alignments and phylogeny reconstruction us-
ing the PhyML (Phylogenetic estimation using Maximum Likeli-
hood) software (Guindon et al. 2010) with 1000 bootstraps. As
shown in Supplemental Figure S2, the tree revealed two major
clusters, the upper one containing sequences resembling POLR3G
and the lower one containing sequences resembling POLR3GL,
with the D. melanogaster, C. elegans, and the C. intestinalis proteins
falling outside of these two clusters. These observations are con-
sistent with the duplication occurring in a common ancestor of
vertebrates, followed by loss of one gene in P. marinus, the fishes
Gasterosteus aculeatus, Oryzias latipes, and T. rubripes, and the birds
Gallus gallus, Meleagris gallopavo, and Taeniopygia guttata (zebra
finch), and separate events of duplication in Danio rerio and Sper-
mophilus tridecemlineatus.
To examine whether the ancestral protein more closely
resembled POLR3G or POLR3GL, we directly compared the
C. intestinalis and P. marinus proteins to human POLR3G and
POLR3GL (Supplemental Fig. S3). Although theC. intestinalisprotein
fell outside of the POLR3G- and POLR3GL-resembling clusters in the
phylogeny reconstruction tree (Supplemental Fig. S2), itwas closer to
human POLR3GL than human POLR3G (51% vs. 37% amino acid




these two proteins, as was the P. marinus protein (63%vs. 45% amino
acid identities) (see Supplemental Fig. S3C,D). This is consistent with
the ancestral gene being closer to the POLR3GL than the POLR3G
gene.
Two forms of Pol III
The detection of the POLR3GL polypeptide in purified Pol III
preparations suggested that two variants of Pol III, containing
either POLR3G or POLR3GL, might coexist in HeLa cells. Indeed,
antibodies specific for either POLR3G or POLR3GL coimmuno-
precipitated POLR3C but not the other POLR3G subunit, in-
dicating that POLR3G and POLR3GL lie in separate complexes
(Supplemental Fig. S4A). We then fractionated a HeLa whole-cell
extract by gel filtration chromatography and analyzed the result-
ing fractions byWestern blot with antibodies against POLR3A and
POLR3C (Supplemental Fig. S4B,C). POLR3C eluted in two main
peaks, the first also containing POLR3A and eluting with an
Figure 1. Evolution of the POLR3G and POLR3GL genes. (A) The genomic organization of the POLR3G (top line) and POLR3GL (bottom line) genes is
shown with coding parts of exons as thick boxes, noncoding parts of exons as thinner boxes, and introns as lines with the arrowheads indicating the
sense of transcription. The corresponding POLR3G and POLR3GL protein sections are schematized in the middle of the panel. (B) Alignment of
POLR3G and POLR3GL protein sequences showing the borders (arrowheads) of corresponding exons. (C ) Number of POLR3G and BRF homologs in
different species. Species were classified according to species phylogeny. The numbers of detected POLR3G and BRF-related genes are indicated on
the right.
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apparent size corresponding to the full Pol III complex (Supple-
mental Fig. S4C, fractions 10–13), and the second lacking POLR3A
and elutingwith a smaller apparent size (fractions 18–21).We then
used these fractions for immunoprecipitations with either a pre-
immune or an anti-POLR3C antibody. The anti-POLR3C antibody
specifically coimmunoprecipitated POLR3A, POLR3G, and
POLR3GL in fractions from the first peak, and POLR3G and
POLR3GL, but not POLR3A, in fractions from the second peak
(Supplemental Fig. S4D). This further suggests that the first peak
corresponds to the full enzyme and that the second peak con-
tains the trimeric POLR3C/POLR3F/POLR3G subcomplex de-
scribed previously (Wang and Roeder 1997). Thus, POLR3GL,
similar to POLR3G, can be incorporated into the full enzyme,
probably as part of the detachable trimeric subcomplex. Indeed,
in GST pull-down experiments with immobilized GST-POLR3G,
GST-POLR3GL, or GST-GFP as a control, we observed that both
POLR3G subunits directly interacted with POLR3C (Supplemental
Fig. S4E). They did not detectably interact with POLR3F or with
BRF1 and BRF2, suggesting that (1) within the trimeric complex,
POLR3G/POLR3GL have strong interactions only with POLR3C,
and (2) the trimeric complex interacts with BRF1 and BRF2mostly
through subunits other than POLR3G/POLR3GL, consistent
with previous reports showing interactions between POLR3F and
BRF1 (Werner et al. 1993; Wang and Roeder 1997). Most impor-
tantly, for all interactions tested, POLR3GL behaved similarly as
POLR3G.
POLR3G- and POLR3GL-containing Pol III on human genes
The results described above as well as previous results (Haurie
et al. 2010) indicate that there are two forms of Pol III. To de-
termine whether POLR3G- and POLR3GL-containing Pol III tar-
get different Pol III genes, we performed ChIP-seq with IMR90
cells and antibodies directed against POLR3D, POLR3G, POLR3GL,
and BDP1 to map these two forms onto the human genome.
We aligned tags and calculated scores as described in the Methods.
As noted previously (Canella et al. 2010), our anti-POLR3D anti-
body was the most sensitive and scored a total of 494 loci as sig-
nificantly occupied, whereas the anti-BDP1 antibody scored 222
loci as significantly occupied. All loci showing significant BDP1
scores also had significant POLR3D scores. Supplemental Table S2
lists all annotated tRNA genes (whether occupied by Pol III or not)
as well as all other loci found significantly occupied by POLR3D
together with their scores. We compared the results with our pre-
vious results obtained in the slightly different IMR90Tert cell line
(Canella et al. 2010). As indicated in column E of Supplemental
Table S2, we found 29 additional loci occupied by Pol III compared
with our previous list, including one RN5S-related sequence on
chromosome 10 (number 482 in column A); the BCYRN1 gene
(number 181), which codes for BC200RNAand ismostly expressed
in neurons (Martignetti and Brosius 1993); one tRNA-derived se-
quence (number 715); 19 SINEs; and seven other loci (see Sup-
plemental Table S2). This may reflect the much greater sequencing
depth of this study and/or the use of a different cell line as starting
material. On the other hand, 57 loci annotated as SINEs, LINEs, or
‘‘other’’ we had flagged as potentially occupied in our previous
work were below the cutoff in this study (listed on the last page of
Supplemental Table S2); all of these loci had displayed very low Pol
III scores and no detectable BRF1 or BDP1 in our previous study
(see Supplemental Fig. S7; Canella et al. 2010) and are, therefore,
unlikely to be much transcribed even in IMR90Tert cells. Thus,
consistent with our previous results, we find that only a limited
number of genomic loci are occupied by Pol III besides the known
Pol III genes.
We then examined POLR3G and POLR3GL occupancy. We
observed a total of 293 occupied loci occupied by POLR3GL and/or
POLR3G (Supplemental Table S2). Since these loci correspond to
thosewith the highest POLR3D scores, it is highly likely that, as for
the anti-BDP1 antibody, our anti-POLR3G and anti-POLR3GL an-
tibodies are less sensitive than the anti-POLR3D antibody, al-
though it is possible that some loci are occupied by partial Pol III
complexes. As shown in Figure 2A, we observed both POLR3G and
POLR3GL on Pol III genes with type 1, 2, and 3 promoters. More-
over, for all Pol III–occupied loci, POLR3G and POLR3GL scores
were highly correlated (Spearman correlation coefficient = 0.87)
(Fig. 2B). Most genes displayed higher occupancy by POLR3G
compared with POLR3GL except for some genes with very low
scores, as visualized by the regression line (red) crossing the x = y
line (blue) (Fig. 2B). This is also visualized in theMvA plot in Figure
2C, showing, first, most genes with a negative POLR3GL/POLR3G
score difference and, second, the 2.5% genes displaying the largest
(orange dots) and smallest (light blue dots) POLR3GL/ POLR3G
score differences toward the lower and higher end of the score
means, respectively. In fact, among the 19 loci with the largest
POLR3GL/POLR3G ratio in Figure 2C, only one (indicated in or-
ange in columns I–L of Supplemental Table S2, page 1) had either
a POLR3Gor a POLR3GL score above the cutoff, and it corresponds
to a locus of unknown function. Among the 19 loci with the smallest
POLR3GL/POLR3G ratio, 18 (indicated in turquoise in columns I–L
of Supplemental Table S2) had either a POLR3G or a POLR3GL score
above the cutoff; one is a RNU6 gene (U6-9), another the VTRNA1-2
gene (HVG 2), and all others are tRNA genes.
Thus, not only were both forms of the polymerase present on
the large majority of Pol III–occupied loci, the proportion of each
form was mostly constant from gene to gene, with perhaps a small
bias toward more POLR3GL-containing RNA Pol III on the weakly
occupied loci and more POLR3G-containing RNA Pol III on the
highly occupied loci. These data do not offer strong support to the
possibility that the two forms of Pol III might specifically target
different genes. Nevertheless, it could still be possible that the two
forms occupy different genes in different types of cells or tissues, in
particular when one of the Pol III forms ismuchmore present than
the other.
POLR3G and POLR3GL are differentially expressed under
different conditions and in different cell types
To identify conditions or cell types likely to have different amounts
of POLR3G- and POLR3GL-containing Pol III, we measured
POLR3G and POLR3GL mRNA levels by real-time PCR in different
cell types and under different conditions. In human IMR90Tert
cells, serum starvation (Supplemental Fig. S5A) resulted in a de-
crease in the ratio of POLR3G over POLR3GL mRNA, as did in-
creasing confluency (Supplemental Fig. S5B). Moreover, the
POLR3G-over-POLR3GL ratio was smaller in a primary culture of
human foreskin tissue (4A cells) consisting of fully differentiated
fibroblasts from young individuals than in a primary culture of
human fetal dermal fibroblasts (Feo cells) that has large expansion
capabilities (Supplemental Fig. S5C). To have access to a fully dif-
ferentiated, normal tissue, we tested mouse liver and, as a com-
parison, mouse hepatocarcinoma cells (Hepa 1-6). Since POLR3G
mRNA had not been detected in human liver (Haurie et al. 2010),
for controls for themouse liver experimentwe usedUcp1 and Pdk4,




Figure S5, D and E, Polr3g mRNA was clearly present in mouse
liver, but the Polr3g-over-Polr3gl ratio wasmuch lower in normal
liver compared with Hepa 1-6 cells. Thus, in all cases tested,
POLR3GL mRNA was relatively more abundant than POLR3G
mRNA in nondividing cells compared with highly dividing
cells.
Figure 2. POLR3G and POLR3GL occupy largely the same loci in human IMR90 cells. (A) POLR3G and POLR3GL occupy all three types of Pol III
promoters. UCSC Browser view of type 1 (RN5S), type 2 (TRNA), and type 3 (RNU6ATAC) Pol III genes showing occupancy by BDP1, POLR3D, POLR3G, and
POLR3GL, as well as the input. The x-axis shows the genomic location; the y-axis shows sequence tag accumulation. The scales on the y-axes are similar for
all factors. (B) Spearman’s rank correlation of the POLR3G versus POLR3GL scores. (c) x-axis, POLR3G scores; y-axis, POLR3GL scores; in blue the x = y line;
in red, the regression line. (b) Correlation coefficient. (a) Distribution histogram representing, for each POLR3G score interval of 0.2 (see x-axis scale at the
bottom of c), the number of genes in that interval (y-axis at the right of the panel: The numbers in green correspond to the lowest, middle, and highest
number of genes). (d) As in a, but for each POLR3GL score interval of 0.2. (C ) MvA plot with the score means [(POLR3GL score + POLR3G score)/2] on the
x-axis and the score difference (POLR3GL score  POLR3G score) on the y-axis. All scores are in log2 (see Supplemental Table S2).
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Pol III–occupied loci in mouse liver and mouse
hepatocarcinoma cells
We chose to compare genome-wide POLR3G and POLR3GL oc-
cupancy inmouse liver andHepa 1-6 cells, as (1) these two samples
displayed very different Polr3g over Polr3glmRNA ratios and (2) we
were interested in determining POLR3G and POLR3GL occupancy
in a normal tissue in addition to cultured cells. We performed
ChIP-seq with antibodies directed against POLR3D, POLR3G, and
POLR3GL in biological replicates (two pools of three mouse livers
and two cultures of Hepa 1-6 cells). We identified significantly
occupied regions and calculated scores as above for the human
sample (see Methods).
Supplemental Table S3 shows all the annotated tRNA genes
(whether occupied or not) as well as all loci found to be signifi-
cantly occupied by Pol III in mouse liver, mouse Hepa 1-6 cells, or
both.We first compared the results obtained for POLR3D inmouse
liver with our previously published POLR3D results in the same
tissue (Canella et al. 2012). As shown in Figure 3A, the correlation
of scores for the tRNA genes and SINEs identified by Canella et al.
(2012) was extremely high (Spearman correlation coefficient
0.98), which is remarkable given that the two experiments were
done at different times, by different people, and were sequenced
on different machines (Illumina Genome Analyzer II in Canella
et al. [2010, 2012] and Illumina HiSeq 2000 in this work). How-
ever, seven Rn5s (5S) and seven tRNA genes above the cutoff in
Canella et al. (2012) were below the cutoff in this study (note,
however, that all but n-Tg4 [number 93] and n-Te18 [number 355]
are above the cutoff in Hepa 1-6 cells) (indicated in yellow in
columnD of Supplemental Table S3) and reciprocally for 26 tRNA
genes (indicated in light green in column D of Supplemental
Table S3).
When considering loci significantly occupied either in the
liver or in Hepa 1-6 cells or in both, we uncovered another 136
loci (indicated in column D of Supplemental Table S3), in-
cluding one Rn5s locus on chromosome 6, outside of the cluster
of Rn5s genes on chromosome 8, and encoding a divergent 5S
RNA; the Bc1_Mm_scRNA locus, encoding Bc1 RNA, a tran-
script previously described as neural-specific (Martignetti and
Brosius 1995) and corresponding to human BCYRN1 (BC200)
(Martignetti and Brosius 1993); 14 Rn4.5s loci; 95 SINEs, most
of them from the B2 family; and 25 NA loci (Fig. 3B). The Rn4.5s
loci (also referred to as 4.5S RNAH), whose function is un-
known, are intriguing; they are located, like the ones we pre-
viously described (Canella et al. 2012), on chromosome 6 but
are embedded in a tandemly repeated 4.3-kb sequence (which
may exist at a much higher copy number than represented in
the genome assembly) (Schoeniger and Jelinek 1986). Note that
Rn4.5s loci are different from the 4.5S RNAI genes described by
Gogolevskaya and Kramerov (2010), which correspond to B4A
SINEs (see Supplemental Table S3, lines 243, 246, and 250;
Canella et al. 2012), and from the 4.5S HybRNA genes described
by Trinh-Rohlik and Maxwell (1988), which we could not find
in the Mm9 genome assembly. Another 16 LINEs, five Rn
(rRNA) repeats and nine NA loci (labeled in red in columns A
and C of Supplemental Table S3) were considered unreliable
(see Methods) and were excluded, therefore, from the analyses
below. Supplemental Table S3 thus lists 701 loci, of which we
consider 529 significantly and reliably occupied by Pol III ei-
ther in mouse liver or hepatocarcinoma cells or in both, with
the rest representing unoccupied tRNA genes and unreliable
loci.
Differential genomic occupation by Pol III in mouse liver
and Hepa 1-6 cells
We then examined whether loci were differentially occupied in
mouse liver and Hepa 1-6 cells by considering the POLR3D
scores as a measure of occupancy by both Pol III forms. When all
loci were considered, there was an increase in the median and
the mean of Pol III occupancy scores in Hepa 1-6 cells relative to
liver cells, as shown in the upper left panel in Figure 3C. Simi-
larly, there was an increase when tRNA genes, Rn5s genes, other
Pol III genes, SINEs, or NA regions were considered separately
(Fig. 3C).
To get an idea of the behavior of individual loci, we applied
the limma linear model fitting on the genes scores (Smyth 2004,
2005) to determine adjusted P-values of the fold change in Hepa
1-6 cells versus liver (Supplemental Table S3, columns AD, AE, and
AF), and we then plotted the score differences over the score
means, as shown in Figure 3D. As indicated by the box plots in Fig.
3C, the large majority of loci were either only (dark blue circles; for
list, see Supplemental Table S4) or more (light blue circles; for list,
see Supplemental Table S4) occupied in Hepa 1-6 cells compared
with liver. Among the more occupied were mostly tRNA (161) and
Rn5s genes (42), the rest corresponding to ‘‘other Pol III genes’’ (13
out of 15, the only missing ones being the Rn7s genes, which
remained unchanged), SINEs (19), and Rn4.5s loci (two). Thus,
most tRNA, Rn5S, and other Pol III genes were more occupied in
Hepa 1-6 cells than in liver, consistent with the idea that Pol III
transcription is overactivated in cancer cells (White 2005; Johnson
et al. 2008). Among the 63 loci only occupied inHepa 1-6 cells were
mostly SINEs and NA loci (39 loci), with only 16 tRNA and eight
Rn5s gene loci.
Nevertheless, a number of genes appeared either exclusively
(Fig. 3D, red circles and dots; for list, see Supplemental Table S4) or
preferentially (Fig. 3D, orange circles and dots; for list, see Sup-
plemental Table S4) occupied in liver cells. In examining these loci
further, we noticed that several of them appeared deleted or rear-
ranged in Hepa 1-6 cells, as suggested by interrupted peaks or total
or near total absence of tags, even in the input sample. A few ex-
amples of apparent complete (three upper panels) or partial (three
lower panels) deletions are shown in Supplemental Figure S6.
Strikingly, nearly all of the 105 tRNA genes in the large cluster on
chromosome 13, extending over 2.37 million base pairs (from
position 21252654 to 23622288), appeared heavily altered/
rearranged in Hepa 1-6 cells, and the same was true for several
other tRNA genes. Because such rearranged regions give rise
to tags that cannot be aligned to the reference genome, the
resulting Hepa 1-6 scores for these regions are artificially low.
When these loci (indicated as red and orange dots in Fig. 4B and
listed in Supplemental Table S4) were removed from the picture,
we were left with 66 loci only occupied, and two loci more oc-
cupied, by Pol III in liver: 45 of which were SINEs, 16 were NA
loci, and seven were tRNA genes.
Thus, the large majority of Pol III–occupied loci, including
most tRNA genes, aremore occupied in Hepa 1-6 cells than in liver,
and among those more occupied in liver, most are SINEs of un-
known function. Moreover, of the 158 tRNA genes that were un-
occupied in liver, all but 16 remained so in Hepa 1-6 cells, sug-
gesting that for the vast majority of tRNA genes, transformation
results in higher occupation of active genes rather than activation
of genes that were silent. As an example, chromosome 6 contains
a large cluster of 51 n-TC genes (tRNA cysteine genes), all of which




Figure 3. Pol III–occupied loci in mouse liver and Hepa 1-6 cells. (A) Spearman’s rank correlation of scores obtained by Canella et al. (2012) and in this
work. The loci considered include all tRNAs and SINEs. (c) x-axis, POLR3D scores in this work; y-axis, POLR3D scores by Canella et al. (2012); in blue, the x = y
line; in red, the regression line. (b) Correlation coefficient. (a) Distribution histogram representing, for each POLR3D 2013 score interval of 1 (see x-axis at the
bottom of c), the number of genes in that interval (y-axis at the right of the panel: The numbers in green correspond to the lowest,middle, andhighest number
of genes). (d) As in a but for each POLR3D 2012 score interval of 0.5. (B) List of additional, Pol III–occupied loci identified in this work compared with that of
Canella et al. (2012). (C ) Box plots showing scores in replicate 1 (Rep1) and replicate 2 (Rep2) samples from liver or Hepa 1-6 cells, as indicated on the x-axis.
The y-axis shows scores in log2. Genes with scores below the cutoff (see Methods) are represented by gray dots. The median is indicated by the black
horizontal bar, themean of genes above the cutoff by the red dot, and themean of genes below the cutoff by the black dot. The genes shown on the various
panels correspond to the lists on the various pages of Supplemental Table S3. (D) MvA plot illustrating differential Pol III occupation in liver versus Hepa 1-6
cells. The x-axis shows scoremeans [(POLR3Dmean score in liver + POLR3Dmean score in Hepa 1-6 cells)/2], and the y-axis score differences (POLR3Dmean
score in Hepa 1-6 cells  POLR3D mean score in liver). All scores are in log2 (see Supplemental Tables S3, S4).
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by >150,000 bp from the rest of the cluster. In Hepa 1-6 cells, all of
these genes remain silent except for n-Tc57, which is more occu-
pied. In contrast, a number of SINEs silent in liver were apparently
activated de novo in Hepa 1-6 cells.
POLR3G and POLR3GL occupy the same loci
in mouse liver and mouse hepatocarcinoma cells
Having identified Pol III–occupied loci inmouse liver andHepa 1-6
cells, we then compared POLR3G and POLR3GL occupancy on
these loci. As described above for human cells, we identified fewer
loci occupied by POLR3G and/or POLR3GL compared with
POLR3D, and these loci again corresponded to the loci with the
highest POLR3D scores, consistent with the anti-POLR3G and
anti-POLR3GL antibodies being less efficient than the anti-
POLR3D antibodies. Figure 4A reproduces the POLR3D box plots
shown in Figure 3C, upper left panel, and shows similar box plots
for POLR3G and POLR3GL. Similar to what was observed for total
Pol III occupancy as reflected by POLR3D scores, POLR3G scores
were on average higher inmouseHepa 1-6 cells than inmouse liver
cells. In contrast, POLR3GL average scores were very similar in
both types of cells. This suggests that the increase in Pol III occu-
pancy in Hepa 1-6 cells compared with liver is provided by
POLR3G-containing Pol III.
We then selected the loci considered as occupied by Pol III as
determined by the presence of POLR3D, and examined whether
the usage of one Pol III form compared with the other one was
similar among genes and in the two different cell types. As shown
in Figure 4, B and C, the occupancy by each of these subunits,
whether in mouse liver or in Hepa 1-6 cells, was highly correlated
with POLR3D occupancy scores, indicating that the more a gene is
POLR3D-occupied and, by extension, probably transcribed in
a given cell type, the more it is occupied by both POLR3G and
POLR3GL. Indeed, in each cell type, the correlation between
POLR3G and POLR3GL occupancy was similarly very high (liver:
0.96; Hepa 1-6: 0.98). Importantly, in mouse liver, the regression
line (red line) for the POLR3G and POLR3GL score correlation was
above the x = y line (blue line), indicating that in this tissue, scores
were almost always higher for POLR3GL than for POLR3G,
whereas in Hepa 1-6 cells, the opposite was observed, indicating
that in this case, scores were almost always higher for POLR3G
than for POLR3GL. Indeed, the log2 ratios of POLR3G over
POLR3GL scores were almost always negative in mouse liver and
almost always positive in hepatocarcinoma cells (Fig. 4D).
To determinewhether any particular gene escaped the general
trend described above, we used limma (Smyth 2004) to compare
the POLR3G-over-POLR3GL score ratios in liver versus Hepa 1-6
cells (Supplemental Table S3, columns AG, AH, and AI). When
considering the loci that were (1) significantly occupied by POLR3D
in at least one cell type and (2) significantly occupied by either
POLR3G or POLR3GL in at least one cell type, we found amajority
(293) of loci with a higher POLR3G/POLR3GL ratio in Hepa 1-6
comparedwith liver, as expected. One locus (NA_21) had a slightly
decreased ratio (LogFC = 0.882) in Hepa 1-6 compared with liver,
and the remaining 46 loci showed no significant change (see
Supplemental Table S3, column AI).
Together, these results show, first, that both subunits are
generally present at all Pol III–occupied loci in the same pro-
portion. We did not find any locus significantly occupied only by
POLR3G or POLR3GL or displaying a very different ratio of occu-
pancy by these two subunits compared with the bulk of Pol III–
occupied loci. Thus, the pattern of genome-wide occupancy by
POLR3G- and POLR3GL-containing Pol III argues against POLR3G
or POLR3GL serving to target Pol III differentially to certain genes.
Second, the results indicate that the general ratio of POLR3G and




POLR3GL occupancy varies in different tissues and is higher in
cancer liver cells compared with normal liver cells.
The promoters of the genes encoding POLR3G and POLR3GL
are differentially occupied by the oncogene MYC
The observation that the POLR3G and POLR3GL genes are differ-
entially expressed under various conditions and in different cell
types indicates that they are controlled by different mechanisms.
Our results (see Supplemental Fig. S5) and those of others (Haurie
et al. 2010;Wong et al. 2011) suggest that cell proliferation is likely
to be one of the factors affecting their expression. The oncogene
MYC is a transcription factor broadly involved in the cellular mi-
togenic and growth responses and is very often up-regulated in
cancerous cells (Eilers and Eisenman 2008; Meyer and Penn 2008;
Dang 2012).MYCbinds as a dimer withMAX to sequences referred
to as E-boxes. The E-box consensus sequence is CANNTG, with the
palindromic sequence CACGTG constituting a high affinity site.
Although we did not find CACGTG sequences close to POLR3G
and POLR3GL transcription start sites (TSSs), we observedmultiple
CANNTG sequences. We thus took advantage of recently pub-
lished data (Lin et al. 2012) describing genome wide MYC occu-
pancy in P493-6 cells, which can be induced to express ectopic
MYC, as well as in other cell lines, to examine MYC presence close
to the POLR3G and POLR3GL TSSs.
Both the POLR3G and POLR3GL genes are under the control
of bidirectional promoters with closely located divergent TSSs
(Fig. 5A). Nevertheless, it is clear that upon induction of ectopic
MYC in P493-6 cells, there is accumulation of MYC and RNA Pol II
at the POLR3G TSS. In contrast, there is no detectable MYC at the
POLR3GLTSS, even after 1 h and 24h ofMYC induction (Fig. 5B, cf.
middle and lower panels to upper panel), when the ectopic MYC
protein accumulates to 76,500 and 362,000 molecules per cell,
respectively (Lin et al. 2012).We also examinedMYCoccupancy in
two pairs of cell lines studied by Lin et al. (2012): (1) primary
glioblastoma U87 cells and MM.1S malignant B-lymphocytes,
which are both transformed cell lines but differ in their MYC ex-
pression levels, with U87 cells containing 4.5 times fewer MYC
molecules per cell than MM.1S cells (Lin et al. 2012), and (2)
H128_1 and H2171 cells, two subtypes of small-cell lung carci-
noma lines, again exhibiting lower and higher levels of MYC, re-
spectively (Lin et al. 2012). In all these cases, MYC was detected
exclusively at the POLR3G TSS, with the possible exception of
MM.1S cells, where a very small peak was detected downstream
from, albeit not at, the POLR3GL TSS (Fig. 5C,D).
The presence of MYC on the POLR3G but not the POLR3GL
TSS, suggests that the POLR3G promoter is activated by MYC to
allow for increased production of a POLR3G subunitwhen the cells
require higher levels of Pol III. We checked whether we could de-
tect MYC on the promoters of the genes encoding all the other Pol
III subunits. Indeed, we observed MYC binding over the TSSs of all
other Pol III subunit-encoding genes, namely, POLR3A, -B, -C, -D,
-E, -F, -H, -K, and CRCP (RPC9) in cells expressing high levels of
MYC (Supplemental Fig. S7). For the promoters of genes encod-
ing subunits common to Pol III and either Pol I (POLR1C/AC1,
POLR1D/AC2) or Pol I and II (POLR2E/ABC1, POLR2F/ABC2,
POLR2H/ABC3, POLR2K/ABC4, POLR2L/ABC5), MYC occupancy
was less prominent but could be observed in all cases in at least one
of the cell lines (data not shown). Thus, the POLR3GL gene is ex-
ceptional among genes encoding Pol III subunits in that its TSS is
apparently not bound byMYC, even in cells with highMYC levels.
Discussion
The availability of genome sequences from many organisms has
revealed that gene duplication followed by retention of two
functional copies is widespread (for reviews, see Prince and Pickett
2002; Long et al. 2003; see also Chen et al. 2010; Ross et al. 2013).
According to classicalmodels, duplicated genes can have twomain
fates. The one considered most likely is the degeneration or loss
through genome remodeling of one of the copies, a process known
as nonfunctionalization. The other, which is expected to be
much less frequent, is neo-functionalization, i.e., the acquisition,
throughmutations in either the coding or the regulatory sequence,
of a new function. However, the frequency of functional dupli-
cated genes in genomes is much higher than would be expected
from this model alone (Prince and Pickett 2002). An alternative
model, known as the duplication-degeneration-complementation
(DDC) model, provides an explanation for the prevalence of du-
plicated genes (Force et al. 1999; for review, see Prince and Pickett
2002). In the DDC model, each duplicated gene can acquire inde-
pendent degenerative mutations affecting one of several subfunc-
tions, which are still provided by the other copy (subfunction-
alization). Given the combinatorial mechanism of transcription
regulation, in which several short binding sites provide, alone or in
combinations, different functions such as tissue- or stage-specific
expression, regulatory sequences have been proposed to be a likely
target for such mutations (Force et al. 1999).
Human cells contain two genes encoding two versions of the
Pol III POLR3G subunit with 46% identical residues, each of which
can be incorporated into RNA Pol III (Haurie et al. 2010; this work).
The genomic structure of the two genes, which display close to
identical exon organization with respect to the protein-coding
sequence, indicates a DNA-based duplication event. A comparison
of available sequences from a number of organisms suggests that
the two genes arose from the duplication of a common ancestor
gene in vertebrates. This may have been as a result of a small du-
plication or one of the two genome-wide duplications commonly
thought to have occurred in vertebrate genomes (2R hypothesis)
(Makalowski 2001; Kasahara 2007), before the divergence of the
ancestral lamprey and Gnathostomata lineages (Smith et al. 2013).
The POLR3G/POLR3GL duplication was apparently followed
by the loss of a gene in some organisms (although we cannot ex-
Figure 4. POLR3G and POLR3GL occupy largely the same loci. (A) Box
plots showing scores in replicate 1 (Rep1) and replicate 2 (Rep2) samples
from liver or Hepa 1-6 cells, as indicated on the x-axis. The y-axis shows
scores in log2. Genes with scores below the cutoff (see Methods) are
represented by gray dots. The median is indicated by the black horizontal
bar, the mean of genes above the cutoff by the red dot, and the mean of
genes below the cutoff by the black dot. The four box plots on the left are
reproduced from Figure 3C, upper left panel. (B) Spearman’s rank corre-
lation of POLR3D and POLR3G (d), POLR3D and POLR3GL (g), or POLR3G
and POLR3GL (h) scores in liver cells: In blue, the x = y line; in red, the
regression line. (b,c,f) The correlation coefficients corresponding to panels
d, g, and h, respectively. (a) Distribution histogram representing, for each
POLR3D score interval of 0.5 (see x-axis at the bottom of g), the number of
genes in that interval (y-axis at the right of the panel: The numbers in green
correspond to the lowest, middle, and highest number of genes). (e) As in
a but for each POLR3G score interval of 0.5 (see x-axis at the bottom of h).
(i) As in a but for each POLR3GL score interval of 075. (C ) As in B but in
Hepa 1-6 cells. (D) Box plots showing POLR3G-POLR3GL score differences
(in log2) in replicate 1 (Rep1) and replicate 2 (Rep2) samples from liver or
Hepa 1-6 cells, as indicated on the x-axis. The y-axis shows score differ-
ences (in log2). Genes with scores below the cutoff (see Methods) are
represented by gray dots. The median is indicated by the black horizontal
bar, the mean of genes above the cutoff by the red dot, and the mean of
genes below the cutoff by the black dot.
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clude the possibility that the apparent lack of a second gene reflects
in some cases problems with genome assemblies) and a second
duplication in others. Among vertebrates, the gene present in
the agnath P. marinus and the fishes G. aculeatus, O. latipes, and
T. rubripes codes for a protein with higher amino acid sequence
identity to humanPOLR3GL thanhumanPOLR3G,whereas in the
birds G. gallus, M. gallopavo, and T. guttata, the remaining copy
codes for a protein closer to POLR3G. This may reflect a period
duringwhich the two genes, although structurally distinguishable,
remained functionally redundant in some species, allowing loss of
one or the other copy. In contrast, all eutherians, metatherians,
and prototherians examined have at least two copies, consistent
with both genes having acquired and fixed separate functions in
the common ancestor of mammals.
A different function for the POLR3G and POLR3GL genes is
experimentally supported by the work of Haurie et al. (2010), who
observed that suppression of POLR3GL expression by siRNA
resulted in cell death, whereas suppression of POLR3G had no
deleterious effect under normal growth conditions but inhibited
the formation of colonies in soft agar. Here, we have examined
whether POLR3G-containing Pol III and POLR3GL-containing Pol
III recognize different target genes, in the same way as BRF1 and
BRF2 recognize specifically type 1 and 2 Pol III promoters, in the
first case, and type 3 promoters, in the second (Canella et al. 2010;
Carriere et al. 2012; James Faresse et al. 2012). For this purpose, we
have performed genome-wide ChIP-seq experiments with anti-Pol
III antibodies in human and mouse cultured cells as well as in
mouse liver. From these experiments, we can refine our previous
lists of Pol III–occupied loci in both human and mouse cells and
confirm that apart from the known Pol III genes, relatively few loci
are clearly occupied by Pol III; we find 26 SINEs clearly occupied by
Pol III in human cells, 31 in bothHepa 1-6 andmouse liver cells, 36
only in Hepa 1-6, and 60 only in liver cells. These numbers are
lower (Barski et al. 2010; Moqtaderi et al. 2010; Kutter et al. 2011;
Carriere et al. 2012) or grossly similar (Oler et al. 2010; Raha et al.
2010) to those reported by others, which may reflect biological
differences in the cell lines used, as well as the stringency of the
filters applied. We suspect that our lists contain very few false
positives but may well be missing loci occupied at very low levels.
When comparing Pol III occupancy in liver and Hepa 1-6
cells, we observed some SINEs more, or only, expressed in liver.
However, consistent with previous findings reporting increased
RNA Pol III activity in cancer cells (for a review, see White 2005;
Johnson et al. 2008), the large majority of Pol III–occupied loci
were more occupied in hepatocarcinoma cells than in liver cells.
For example, 5S genes were collectively more occupied by Pol III
in Hepa 1-6 cells compared with liver cells. Notably, eight 5S genes
in the chromosome 8 cluster that scored below the cutoff in liver
(and that scored among the nine lowest occupied 5S genes in
Canella et al. 2012) were clearly occupied in Hepa 1-6 cells. Of
note, most tRNA genes that were silent in liver cells (as opposed to
occupied at low levels) remained so in Hepa 1-6 cells, suggesting
that they are embedded in a deeply repressed chromatin envi-
ronment. In contrast, some SINEs were de novo transcribed in
Hepa 1-6 cells, perhaps reflecting genomic rearrangements in these
cells rather than differential regulation in the same environment.
Among the loci appearing more occupied in liver compared with
Hepa 1-6 cells, many, in particular tRNA genes, were clearly de-
leted, rearranged, or otherwise changed in Hepa 1-6 cells, which is
likely to lead to underestimated scores in these cells. Despite these
score uncertainties, combining the scores for tRNA genes by iso-
type revealed increased Pol III occupancy for all amino acids except
for selenocysteine, histidine, and asparagine: In these cases, the
corresponding tRNA genes did not appear rearranged in Hepa 1-6
cells, and yet the combined scores were barely higher (SeC) or




lower (His and Asn) in Hepa 1-6 cells compared with liver (data not
shown). It will be interesting to determine whether this is also the
case in othermalignant cells or whether it reflects a particularity of
Hepa 1-6 cells. In the case of selenocysteine, this may be quite
general as there are only two genes, n-Ts1 and n-Ts2, one of which
(n-Ts1) is silent in liver and remains so in Hepa 1-6 cells.
To determine whether the POLR3G- and POLR3GL-contain-
ing forms of Pol III might specialize to recognize different targets,
we compared POLR3GandPOLR3GL scores in human IMR90 cells.
Most Pol III–occupied loci yielded higher scores for POLR3G
compared with POLR3GL, but because the anti-POLR3G and anti-
POLR3GL antibodies may have different affinities, the absolute
numbers cannot be interpreted. Importantly, however, the pro-
portion of POLR3G and POLR3GL was very similar on all but
a few genes. This result strongly suggests that within this cell line,
POLR3G- and POLR3GL-containing RNA polymerases are re-
cruited to the very same promoters. Since ChIP-seq results, like any
biochemical experiment, reflect the average situation in all cells, it
is possible that some genes are transcribed exclusively by, for ex-
ample, POLR3G-containing Pol III in some cells and POLR3GL-
containing Pol III in others. It remains that unlike the BRF1 and
BRF2 transcription factors, which recognize specifically different
subsets of Pol III promoters, both forms of polymerases have the
capacity to recognize the same promoters.
Since the two isoforms were found to be differentially
expressed (Haurie et al. 2010), we examined POLR3G and POLR3GL
expression in various cells and conditions. Our results showhigher
POLR3G expression relative to POLR3GL expression in dividing cells
compared with resting cells, consistent with the observation that
POLR3G (RPC32-alpha) increases relative to POLR3GL (RPC32-
beta) during cellular transformation and decreases during dif-
ferentiation (Haurie et al. 2010). In particular, we found much
higher Polr3gl expression than Polr3g in normal mouse liver,
where hepatocytes are in G0, a situation that was reversed in
mouse hepatocarcinoma cells, which divide approximately every
24 h.We thus used these two types of cells to perform a genome-wide
ChIP-seq experiment with antibodies directed against POLR3D,
POLR3G, and POLR3GL.
In both types of mouse cells, we observed a high correlation
between POLR3D and POLR3G, and POLR3D and POLR3GL, occu-
pancy scores, with POLR3G scores generally lower than POLR3GL
scores in liver cells and higher than POLR3GL scores in Hepa 1-6
cells. Although we cannot interpret these results in terms of ab-
solute amounts, given that different antibodies with potentially
different affinities were used, it is clear that the relative ratios of
both subunits change in the two cell lines. Nevertheless, however,
within one cell line, the ratios of POLR3G and POLR3GL scores
were, like in human IMR90 cells, highly constant fromone locus to
another, as illustrated by the high correlation between POLR3G
and POLR3GL occupancy in both types of cells. Together, the ge-
nome-wide localization results of POLR3G and POLR3GL do not
support the idea that the incorporation of POLR3G or POLR3GL
into Pol III confers a different specificity to the enzyme for its target
genes.
If the different functions of the two forms of Pol III are not
related to transcription of different target genes, what are they?
One possibility is that the two enzymes respond differently to
regulators such as MAF1, which represses Pol III transcription by
direct binding to the enzyme (Upadhya et al. 2002; Oficjalska-
Pham et al. 2006; Reina et al. 2006; Vannini et al. 2010). Another is
that POLR3GL or POLR3G has a function completely unrelated to
its role as a subunit of Pol III, for example, as part of another
complex. However, the DDC model argues that complementary
mutations in duplicated genes will frequently affect regulatory
elements rather than the function of the protein itself (Force
et al. 1999). Indeed, we found MYC bound to the TSS of all genes
encoding Pol III subunits, suggesting that they are responsive to
activation by MYC, with the notable exception of the POLR3GL
gene. Perhaps MYC activation of the POLR3GL promoter is not
desirable because it might lead to activation of the closely spaced
ANKRD34A promoter. It is the presence of the POLR3G gene then
that allows the cell to produce increased levels of this subunit
when needed. Thus, the POLR3G gene duplication did not lead to
two forms of Pol III with different specificities for target genes but
rather to two transcription units with different regulation poten-
tials, as illustrated in Figure 6A. If this is the main function of the
duplication, the cell death observed by Haurie et al. (2010) upon
suppression of the POLR3GL genemost likely results from very low
levels of POLR3G expression under certain conditions, as illus-
trated in Figure 6B. It seems likely, then, that the POLR3G/
POLR3GL duplication was retained as a result of DDC, perhaps
with neo-functionalization of the regulatory regions related to the
proximity for each of the two genes of a divergent promoter.
The transcriptional apparatus is highly conserved, withmulti-
subunit RNA polymerases displaying a strikingly similar catalytic
core and some general transcription factors easily recognizable in
organisms as remote from each other as bacteria, archae, and
mammals (see Carter and Drouin 2010; Vannini and Cramer 2012,
and references therein). Nevertheless, gene duplications have led
to new protein functions, as for BRF1 and BRF2, which recognize
different subsets of promoters (Schramm et al. 2000; Geiduschek
and Kassavetis 2001; SchrammandHernandez 2002; Jawdekar and
Henry 2008; Carriere et al. 2012), or RNA polymerases IV and V,
which appeared in plants through several gene duplications and
are specifically involved in noncoding RNA-mediated gene si-
lencing processes (Haag and Pikaard 2011), as well as to transcrip-
tion units with new regulation potentials, of which the POLR3G/
POLR3GL duplication is an example.
Methods
Cell lines
HeLa, IMR90, IMR90Tert (kindly provided by Greg Hannon, Cold
Spring Harbor Laboratory), FEO and 4A (kindly provided by Lee
Ann Laurent-Appelgate, University of Lausanne), and Hepa 1-6
(kindly provided by David Gatfield, University of Lausanne) cells
were cultured in Dulbecco’s modified Eagle’s medium supple-
mented with 10% fetal bovine serum, 4 mM glutamine, 100 units/
mL of penicillin, and 100 mg/mL of streptomycin. For serum
deprivation (Supplemental Fig. S5A), the medium was removed,
and the cells werewashed two times and then incubatedwith fresh
medium lacking FBS for 4 and 8 h before cell harvesting. Control
cells were handled similarly, but after medium removal, normal
Dulbecco’s modified Eagle’s medium supplemented with 10% FBS
Figure 5. MYC binds to POLR3G but not to POLR3GL TSS. (A) Schematic
of the POLR3G and POLR3GL genomic regions. (B) UCSC Browser views
showing MYC, MAX, and Pol II (antibody directed against the N-terminus
of POLR2A, Santa Cruz sc-899) tag accumulation, as indicated on the
right, on the POLR3G and POLR3GL promoter regions, in P493-6 cells at
time 0, 1 h, and 24 h after induction of MYC, as indicated on the left. The
scales on the y-axes were adjusted to the maximum height of the peaks in
each track, which is indicated on the right of each track, just above the track
identity. (Based on the data of Lin et al. [2012]). (C ) As in B but in U87 and
MM.1S cells. (D) As in A but in SCLC H128_1 and SCLC H2171 cells.
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was used. Similar results were obtained with serum deprivation
protocols performed with medium containing 0.5% FBS rather
than 0% FBS. For analyses of cell density effects (Supplemental Fig.
S5B), growth curves were first established for each cell line in test
experiments. Cells were then seeded at the appropriate concen-
tration to obtain the expected density at the time of harvesting,
18 h later.
Animals
Two pools of three C57BL/6 12-wk-old male mice were killed, and
livers were collected as described below for RNA preparation and
ChIP experiments. All animal care and handling was performed
according to Swiss law for animal experimentation.
Pol III purification
Pol III was purified fromwhole-cell extracts prepared from 48 liters
of the clonal cell line HeLa 9-8 as previously described (Hu et al.
2002). Briefly, the extracts were first fractionated by ammonium
sulfate precipitation. All buffers used after the ammonium sulfate
precipitation except for buffer D100 were supplemented with 0.5
mMPMSF, 1mMpepstatin A, 5mM b-mercaptoethanol, and Sigma
protease inhibitor cocktail (cat no P8849) diluted 1:10000. The
proteins precipitated between 18% and 40% ammonium sulfate
were dissolved in TBS120 buffer (50mMTris-HCl at pH 8.0, 120mM
NaCl, 5% glycerol) to a final salt concentration of 150 mM and
were loaded onto anti-Flag immunoaffinity beads (Sigma). The
anti-Flag beads were rotated overnight at 4°C and washed with 30
bead volumes of TBS300 and 20 bead volumes of TBS150. The bound
proteins were eluted with five bead volumes of a solution con-
taining 300 mg/mL of Flag peptide in TBS150 buffer. The fractions
were pooled, adjusted to 300 mM NaCl and 10 mM imidazole,
and incubated with Ni2-nitrilotriacetic acid (NTA) agarose beads
(Qiagen) overnight at 4°C. The beads
were washed with buffer B (50 mM
NaH2PO4, 20mM imidazole, pH 8.0). The
bound proteins were eluted with five
bead volumes of buffer B containing 300
mM imidazole. The fractions were di-
alyzed against buffer D100 (50 mMHEPES
[pH 7.9], 0.2 mM EDTA, 20% glycerol,
0.1% Tween 20, 100mMKCl, 3 mMDTT,
0.5 mM PMSF).
Mass spectrometry analysis
TCA-precipitated protein pellets were
analyzed at the Proteomics Center of the
Stowers Institute for Medical Research
(Kansas City, MI, USA) for mass spec-
trometry analysis. The pellets were solu-
bilized in Tris-HCl (pH 8.5) and 8 M urea
and then reduced and alkylated with
TCEP (tris-(2-carboxylethyl)-phosphine
hydrochloride, Pierce) and iodoacetamide
(Sigma), respectively. Proteins were di-
gested with endoproteinase Lys-C (Roche)
at 1:100w/w, followedbyTrypsin (Promega)
at 1:100 w/w. Formic acid was added to
5% to stop the reactions. Peptides were
loaded on triple-phase fused-silica micro-
capillary columns (McDonald et al. 2002)
and placed in-line with a Deca-XP ion
trapmass spectrometer (ThermoScientific),
coupled with a quaternary Agilent 1100 series HPLC. A fully au-
tomated seven-step chromatography run was carried out for each
sample, as described by Florens andWashburn (2006). The MS/MS
data sets were searched using SEQUEST (Eng and McCormack
1994) against a database of 61,318 sequences, consisting of 34,521
H. sapiens nonredundant proteins (released by NCBI on 2012-08-
27), 160 usual contaminants (such as human keratins, IgGs, and
proteolytic enzymes), and, to estimate false-discovery rates (FDRs),
randomized sequences derived from each nonredundant protein
entry. Peptide/spectrum matches were sorted, selected, and com-
pared using DTASelect/CONTRAST (Tabb et al. 2002). Combining
all runs, proteins had to be detected by at least two peptides,
leading to FDRs of 1% and 0.2% at the protein and spectral levels,
respectively. To estimate relative protein levels, normalized spec-
tral abundance factors (dNSAFs) were calculated for each detected
protein, as described by Zhang et al. (2010).
Homology and phylogeny analysis
Homology search was performed in a stepwise procedure. A BLAST
search was first performed in genome assemblies available in
Ensembl with human POLR3G (or BRF1) as the query. Candidate
homologs identified in other genomes were then filtered manu-
ally. Proteins sequences were aligned with MUSCLE (Edgar 2004)
and cleaned using BMGE (Criscuolo and Gribaldo 2010). Phyloge-
netic trees were constructed using the PhyML (Guindon et al. 2010)
and drawn with Phylodendron (see http://iubio.bio.indiana.edu/
treeapp/). All software was used with the default parameters.
Antibodies
The antibodies used in this work were rabbit polyclonal anti-
bodies, as follows: anti-human POLR3G SZ3070 antibody (Ab),
raised against peptide DYKPVPLKTGEGEEYML; anti-human
Figure 6. The POLR3G gene duplication leads to neo-functionalization of promoter sequences rather
than gene product. (A) The POLR3G and POLR3GL promoters are differentially regulated, probably at
least in part through exclusive binding of MYC to the POLR3G TSS. (B) Model of POLR3G and POLR3GL
regulation. The model assumes a constant cellular level of POLR3GL and a variable level of POLR3G that
allows adaptation of total Pol III levels to cell growth and proliferation conditions. If the cell loses
POLR3G, the constant expression level of POLR3GL allows survival. If the cell loses POLR3GL, it can




POLR3GL SZ3072 Ab, raised against peptide RPPKTTEDKEETIK;
anti-mouse POLR3G ZCH10075-1430 Ab, raised against peptide
VGFSRGEKLPDVVLK; anti-mouse POLR3GL ZCH10079-1434 Ab,
raised against peptide RPPKSTDDKEETIQK; anti-POLR3D (mouse
and human) CS681 Ab, raised against peptide CSPDFESLLDHKHR
(Chong et al. 2001); anti-human POLR3CCS2125Ab, raised against
peptide DEDAAGEPKAKRPKY; and anti-human BDP1: CS914,
raised against peptideCSDRYRIYKAQK, likeCS913 (Schrammet al.
2000).
Gel filtration
One milliliter of HeLa whole-cell extract was fractionated on
a Superose 6 10/300 GL column (GE Healthcare UK) by FPLC. The
column was first equilibrated with two volumes of TBS300, the
sample was loaded, and 500 mL fractions were collected. Molecular
weights were determined from the elution profile of high molec-
ular weight standards performed under similar conditions fur-
nished by the manufacturer. Fifteen microliters of each fraction
was loaded on a 12% SDS-polyacrylamide gel, and fractionated
proteins were detected with various antibodies. Another 200 mL of
the same fractions was used for immune-precipitation with anti-
POLR3C serum or a preimmune serum as negative control.
GST-pull downs
Recombinant GST-POLR3G, GST-POLR3GL, and GST-GFP were
produced in the BL-21 Escherichia coli strain. After overnight in-
duction, cells were harvested and resuspended in 50 mL of sus-
pension buffer (25 mM Hepes [pH 7.9], 100 mM KCl, 20% Glyc-
erol, 0.5mMPMSF, EDTA-free complete tablet [Roche], and 10mM
b-mercaptoethanol). Cells were incubated with lysozyme at a final
concentration of 100 mg/mL for 20 min on ice. After the addition
of NP-40 to a final concentration of 0.1%, the lysate was homog-
enized with a Dounce homogenizer. GST-tagged proteins were
bound to glutathione-agarose beads, and the sample was rotated
overnight at 4°C. Beadswere thenwashedwith 30 bead volumes of
HEMGN buffer (25 mM Hepes [pH7.9], 150 mM KCl, 12.5 mM
MgCl2, 0.1 mM EDTA, 10% glycerol, 0.1% NP-40 and 0.5 mM
PMSF, EDTA-free Complete tablet [Roche], and 1 mM dithio-
threitol) and 30 bead volumes of TBS150 (containing 0.5mMPMSF,
EDTA-free Complete tablet [Roche], and 1 mM dithiothreitol).
The human POLR3C, POLR3F, BRF1, and BRF2 proteins were
produced with the TnT Quick Coupled Transcription/Translation
System (Promega). Similar amounts of recombinant GST-POLR3G,
GST-POLR3GL, or GST-GFP (negative control) bound to beadswere
then incubated overnight with 15 mL of the TnT-produced pro-
teins. Columns were washed four times with 10 volumes of TBS150
(with 0.5mMPMSF, EDTA-free complete tablet [Roche], and 1mM
dithiothreitol). Proteins bound to the column were then eluted in
Laemmli buffer (60 mM Tris-Cl at pH 6.8, 2% SDS, 10% glycerol,




About 5 million cells were scraped in 5 mL of TRIzol reagent
(Invitrogen) and incubated for 5 min at room temperature. One
milliliter of chloroform was then added; the tubes were inverted
several times tomix the samples and then centrifuged for 15min at
12,000g at 4°C. The RNA-containing aqueous phase was recovered
and added to 500 mL of EtOH for precipitation. RNAwas recovered
after centrifugation for 30 min at 12,000g at 4°C. The pellets
were washed with 70% of EtOH and resuspended in DEPC-treated
water. RNA quality was assessed with the Agilent 2100 Bioanalyzer
(Agilent Technologies) as well as by fractionation on a 1% agarose
gel.
Mouse liver
About 100 mg of snap-frozen liver tissue was disrupted in 1 mL of
TRIzol reagent (Invitrogen) with a TissueLyser (Qiagen). The ho-
mogenate solution was then processed as described above for the
cell lines.
Quantitative RT-PCR
One microgram of total RNA was used for reverse transcription
with oligo-dT primers and the Improm-II reverse transcription
system (Promega). Two microliters of the resulting cDNA was
amplified with 0.4 mM specific cDNA (exon–exon junction)
primers. The reactions, which contained the Fast SYBR Green
MasterMix (Roche), were analyzed by quantitative PCR on a Rotor-
Gene-3000 (Corbett, Life Science). The thermal cycling conditions
were optimized according to the manufacturer’s protocol. The re-
sults were analyzed with the software provided with the in-
strument, using the comparative quantification function. The
quantification was normalized to PCRs performed with POLR3C
mRNA-specific primers (Supplemental Fig. S5A–C). PCR reactions
were repeated three times with independent cDNA preparations.
ChIP
Approximately 10 million subconfluent IMR90 cells were used per
ChIP. The protocol used was similar to the one described by
O’Geen et al. (2006). Cells were directly crosslinked in the culture
medium for 7 min with 1% formaldehyde. The chromatin was
sonicated to an average size of 200–600 bp. Livers were perfused
with 5 mL of PBS through the spleen, immediately homogenized
in PBS containing 1% formaldehyde, and then processed as de-
scribed by Ripperger and Schibler (2006). Aliquots of sonicated
chromatin were mixed with different antibodies and incubated
overnight at 4°C on a rotating wheel. Immunoprecipitated mate-
rial was recovered by addition of 15 mL of protein A agarose beads
(preblocked with 10 mg/mL of BSA and 10 mg/mL of salmon sperm
DNA) and incubation for 1 h at room temperature on a rotating
wheel. The beads were washed with dialysis and wash buffer
(O’Geen et al. 2006). De-crosslinking, RNase A treatment, pro-
teinase K treatment, and DNA purification were performed as de-
scribed by O’Geen et al. (2006). The optimal amount of each an-
tibody was determined in test ChIPs analyzed by q-PCR.
Ultra-high-throughput sequencing
Ten nanograms of immunopurified chromatin as well as input
DNA was used to prepare sequencing libraries with the ChIP-seq
Sample Preparation Kit (Illumina; catalog no. IP-102-1001)
according to the protocol supplied by the manufacturer. Se-
quencing libraries were loaded onto one lane of a Genome Ana-
lyzer flow cell (human IMR90 cells) or onto one lane of a HiSeq
2000 flow cell (mouse liver and Hepa 1-6 cells).
Analysis of ChIP-seq data
Tag alignment
The sequence tags obtained after ultra-high-throughput sequenc-
ing were first mapped onto the UCSC Genome Browser versions
mentioned in Supplemental Tables S2 and S3 via the eland_extended
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mode of ELAND v2e in the Illumina CASSAVA pipeline version 1.8.2.
The tags with multiple matches in the genome were then mapped
with the ‘‘fetchGWI’’ software (www.isrec.isb-sib.ch/tagger/) (Iseli
et al. 2007). As in our previouswork, we included tagsmatching up
to 500 times in the genome but did not allow anymismatch for tag
alignment (Canella et al. 2012). The numbers of tags sequenced
with and without redundancy, the numbers of tags aligned onto
the genome, as well as the percentage of tags falling in the list of
loci in Supplemental Tables S2 and S3 are listed in Supplemental
Table S5.
Identification of enriched genomic regions
To identify Pol III–enriched regions in each sample (human IMR90
cells, mouse liver, and mouse Hepa 1-6 cells), we divided the ge-
nome into 400 nucleotide (nt) bins and then compared the tag
counts in the POLR3D immunoprecipitations with the tag counts
in the input in each of those bins. After eliminating the bins with
a similar enrichment level in both IP and Input, we calculated
scores for the remaining 400-nt regions and extracted those re-
gions with a score above the cutoff (see below). For regions corre-
sponding to known Pol III genes, the scores were then calculated
over the RNA coding region, as well as upstream and downstream
sequences as described below. For the regions that did not corre-
spond to known Pol III genes, the scores were recalculated over
a window of minus to plus 200 nt around the peak maxima.
For the IMR90 cells, the method identified 917 enriched re-
gions, of which 568had a POLR3D score above the cutoff. Of these,
we removed 47 loci in satellite regions, as well as 27 regions con-
taining peak trails (i.e., corresponding to bins falling toward the
end of a peak) or peaks with strange shapes. This left a total of 494
loci clearly occupied by POLR3D. For both the mouse liver and
Hepa 1-6 cells, the method identified a total of 1084 enriched re-
gions, of which we kept 589 with scores above the cutoff (see be-
low) in at least one type of cell. Thirty of these regions displayed
peaks with unusual (often rectangular) shapes and were thus not
considered in the analysis (indicated in red in columns A and D of
Supplemental Table S3), leaving 559 loci clearly occupied by Pol III,
plus another two above the cutoff in the work by Canella et al.
(2012) but below the cutoff in both liver and Hepa 1-6 cells in this
study, for a total of 561 loci.
Score calculations
Tags with up to 500 matches in the genome were attributed a
weight corresponding to the number of times theywere sequenced
divided by the number of matches in the genome. For tags se-
quenced multiple times, we established a cutoff at 50, i.e., tags
sequencedmore than 50 times were counted as 50. This allowed us
to include >99% of the data. As shown in Supplemental Figure S8,
the correlation between scores calculated with all redundant tags
counted up to 50 times and all redundant tags counted only once
was very high. Scores were calculated as log2[(immunoprecipitation
tag counts + 30)/(input tag counts + 30)] over regions encompassing
the RNA coding sequence as well as 150 bp upstream of and 150 bp
downstream from the RNA coding region. When two Pol III–occu-
pied loci were closer to each other than 300 bp, the region sepa-
rating the coding regionswas divided into two equal parts, and each
half was attributed to the closest gene for score determination.
Cutoffs
The cutoffs were calculated on the data scaled to a total amount of
25 million tags for the IMR90 cell data and 150million tags for the
mouse liver andHepa 1-6 cell data. For each experiment, the cutoff
for genes considered as not occupied was calculated as follows: (1)
The whole genome was split into 400-bp (the mean size of regions
used to calculate Pol III scores) bins; (2) the scores of these regions
were calculated as described above; (3) the mean and standard
deviation of these scores were calculated, and each region was at-
tributed a P-value by applying the mean and standard deviation to
a normal distribution and comparing it with the real data distri-
bution; (4) the P-value was adjusted with the Benjamini-Hochberg
method to obtain the FDR; and (5) the cutoff chosen was the
lowest score giving a FDR of 0.001 on the whole genome.
Data access
The ChIP-seq data generated in this study have been submitted to
the NCBI Gene Expression Omnibus (GEO; http://www.ncbi.
nlm.nih.gov/geo/) under accession number GSE47849.
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